Ligand Pharmaceuticals | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Amgen USD 1.69B 191M 2025-03
Arrowhead Research USD 27.89M 2.3M 2025-03
Baxter International USD 703M 88M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Glaxosmithkline GBP 2.7B 632M 2024-12
Insmed USD 147.54M 5.03M 2025-03
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
Ligand Pharmaceuticals USD 18.8M 6.8M 2025-03
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.53B 319M 2025-03
Pacira USD 86.78M 7.16M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
Veracyte USD 50.72M 3.47M 2024-12



Ligand Pharmaceuticals Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.